Health Sciences Trust
INVESTMENT APPROACHBlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust utilizes an option writing (selling) strategy to enhance dividend yield.
No assurance can be given that the Trust’s investment objective will be achieved.
|Total Return (%)||30.06||23.49||18.20||-||13.95|
|Market Price Total Return (%)||28.03||23.84||19.94||-||12.98|
|Total Return (%)||15.80||5.29||30.06||88.32||130.68||-||242.19|
|Market Price Total Return (%)||8.29||4.14||28.03||89.94||148.16||-||215.78|
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.
Past distributions are not indicative of future distributions.
as of 29-Aug-2014
|BIOGEN IDEC INC||3.32|
|MERCK & CO INC||3.05|
|ALEXION PHARMACEUTICALS, INC.||2.83|
|JOHNSON & JOHNSON||2.77|
|UNITEDHEALTH GROUP INCORPORATED||2.54|
Allocations are subject to change.
Average Market Cap (Millions)
as of -
as of -
as of 30-Jun-2014
|Type of Options||Single Stock|